Agios stock price target
AGIOS PHARMACEUTICALS, INC. : AGIO Stock Price ... Agios Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group of over 600 rare genetic diseases caused by mutations, or defects, of single metabolic genes. Is It Crazy To Buy Agios Pharmaceuticals Inc. (NASDAQ:AGIO ... Mar 04, 2020 · Guggenheim advised investors in its research note published on September 23, 2019, to Buy the AGIO stock while also putting a $55 price target. The stock had earned Neutral rating from Goldman Markets when it published its report on May 23, 2019. That day the Goldman set price target on the stock to $55. Agios Price Target Cut On Cancer Drug Data Delay ...
Researching Agios Pharmaceuticals (NASDAQ:AGIO) stock? View AGIO's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC
AGIO Stock Price, Forecast & News (Agios Pharmaceuticals) 12 analysts have issued twelve-month target prices for Agios Pharmaceuticals' stock. Their forecasts range from $49.00 to $79.00. On average, they anticipate Agios Pharmaceuticals' stock price to reach $63.10 in the next twelve months. This suggests a possible upside of … Agios Pharmaceuticals, Inc. Common Stock (AGIO) Analyst ... Find the latest analyst research for Agios Pharmaceuticals, Inc. Common Stock (AGIO) at Nasdaq.com. Looking for additional market data? The average price target is $ 0.00 with a high estimate AGIO Stock Price | Agios Pharmaceuticals Inc. Stock Quote ... AGIO | Complete Agios Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
AGIO Stock Price | Agios Pharmaceuticals Inc. Stock Quote ...
Agios Pharmaceuticals, Inc. - AGIO - Stock Price Today - Zacks View Agios Pharmaceuticals, Inc. AGIO investment & stock information. Get the latest Agios Pharmaceuticals, Inc. AGIO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Agios Pharmaceuticals (NASDAQ:AGIO) Price Target Raised to ... Agios Pharmaceuticals (NASDAQ:AGIO) had its target price boosted by BMO Capital Markets from $45.00 to $49.00 in a report released on Monday, The Fly reports. The firm currently has an outperform Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis & News ...
20 Mar 2020 In addition to the average rating from Wall Street analysts, AGIO stock has a mean target price of 63.75. This means analysts expect the stock to
Agios Pharmaceuticals stocks price quote with latest real-time prices, charts, financials, latest news, Based on 10 analysts offering recommendations. Created Real time Agios Pharmaceuticals (AGIO) stock price quote, stock graph, news & analysis. Agios Pharmaceuticals (NASDAQ: AGIO) stock research, profile, news, analyst on Agios Pharmaceuticals, Raises Price Target to $70 Benzinga_NewsdeskFri, Hot Stocks. Agios Pharmaceuticals receives orphan drug designation for mitapivat from EMA » 16:29. 03/30/20 Barclays analyst Peter Lawson initiated coverage of Agios Pharmaceuticals with an Equal Weight rating and $50 price target. 20 Mar 2020 In addition to the average rating from Wall Street analysts, AGIO stock has a mean target price of 63.75. This means analysts expect the stock to
Mar 12, 2020 · The stock had earned Buy rating from Guggenheim Markets when it published its report on September 23, 2019. That day the Guggenheim set price target on the stock to $55. The stock was given Neutral rating by Goldman in its report released on May 23, 2019, the day when the price target on the stock was placed at 55.
Mar 04, 2020 · Guggenheim advised investors in its research note published on September 23, 2019, to Buy the AGIO stock while also putting a $55 price target. The stock had earned Neutral rating from Goldman Markets when it published its report on May 23, 2019. That day the Goldman set price target on the stock to $55. Agios Price Target Cut On Cancer Drug Data Delay ... Biotech Agios Pharmaceuticals continued its selloff Monday as Canaccord Genuity lowered its price target based on skepticism about one of its cancer drugs. Agios stock dropped 10% Friday on AG-221 AGIO Stock Price & Charts | Agios Pharmaceuticals In depth view into AGIO (Agios Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. AGIO - Agios Pharmaceuticals Stock Analyst Ratings ...
Evolution of the average Target Price on AGIOS PHARMACEUTICALS, INC Agios Pharmaceuticals (NASDAQ:AGIO) Stock Rating ... Agios Pharmaceuticals (NASDAQ:AGIO) ‘s stock had its “buy” rating reaffirmed by analysts at Cowen in a report released on Thursday, TipRanks reports. Several other analysts have also recently weighed in on the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $71.00 price target on shares of Agios Pharmaceuticals in a report on Thursday, October 31st. Agios Pharmaceuticals (NasdaqGS:AGIO) - Share price, News ... Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of hematologic malignancies, solid tumors, and rare genetic diseases.